Lonnel Coats
Net Worth

Last updated:

What is Lonnel Coats net worth?

The estimated net worth of Mr. Lonnel Coats is at least $11,392,461 as of 28 Feb 2024. He owns shares worth $1,042,461 as insider and has received compensation worth at least $10,350,000 in Lexicon Pharmaceuticals, Inc..

What is the salary of Lonnel Coats?

Mr. Lonnel Coats salary is $1,150,000 per year as Chief Executive Officer & Director in Lexicon Pharmaceuticals, Inc..

How old is Lonnel Coats?

Mr. Lonnel Coats is 60 years old, born in 1965.

What stocks does Lonnel Coats currently own?

As insider, Mr. Lonnel Coats owns shares in one company:

Company Title Shares Price per share Total value
Lexicon Pharmaceuticals, Inc. (LXRX) Chief Executive Officer & Director 914,359 $1.14 $1,042,461

What does Lexicon Pharmaceuticals, Inc. do?

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

LXRX logo
LXRX
Lexicon Pharmaceuticals, Inc.
$1.14

Lonnel Coats insider trading

Lexicon Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 120,383 N/A N/A
Option
Restricted Stock Units 120,383 N/A N/A
Option
Common Stock 33,333 N/A N/A
Option
Restricted Stock Units 33,333 N/A N/A
Option
Restricted Stock Units 91,364 N/A N/A
Option
Common Stock 91,364 N/A N/A
Purchase
Common Stock 90,000 $1.05 $94,770
Purchase
Common Stock 10,000 $1.01 $10,100
Purchase
Common Stock 10,000 $2.16 $21,600
Purchase
Common Stock 10,000 $2.18 $21,790
Purchase
Common Stock 10,000 $2.5 $24,950
Purchase
Common Stock 40,000 $2.31 $92,400
Option
Restricted Stock Units 33,334 N/A N/A
Option
Restricted Stock Units 84,630 N/A N/A
Option
Common Stock 33,334 N/A N/A
Option
Restricted Stock Units 91,363 N/A N/A
Option
Common Stock 84,630 N/A N/A
Option
Common Stock 91,363 N/A N/A
Option
Common Stock 192,885 N/A N/A
Option
Restricted Stock Units 169,372 N/A N/A
Option
Restricted Stock Units 169,372 N/A N/A
Option
Common Stock 192,885 N/A N/A
Option
Common Stock 116,647 N/A N/A
Option
Restricted Stock Units 116,647 N/A N/A
Purchase
Common Stock 50,000 N/A N/A
Purchase
Common Stock 50,000 $3.13 $156,250
Purchase
Common Stock 3,000 $1.4 $4,194
Purchase
Common Stock 37,000 $1.34 $49,617
Option
Restricted Stock Units 48,101 N/A N/A
Option
Common Stock 48,101 N/A N/A
Option
Restricted Stock Units 24,588 N/A N/A
Option
Common Stock 24,588 N/A N/A
Purchase
Common Stock 10,000 $9.91 $99,100
Purchase
Common Stock 30,000 $12.58 $377,370
Option
Common Stock 19,226 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 19,226 N/A N/A
Option
Common Stock 10,835 N/A N/A
Option
Restricted Stock Units (Phantom Stock) 10,835 N/A N/A

Lexicon Pharmaceuticals key executives

Lexicon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: